EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A rare genetically confirmed case of apparent mineralocorticoid excess syndrome due to a homozygous HSD11B2 variant in a 2-year-old child with severe hypertension: response to targeted therapy

Bashair Alabbasi, Mugahid Elamin, Ghadah Alsallum, Ghada Alzahrany

Clinical and Experimental Pediatrics · 15.08.2026 · 69 (8) · 676-679

DOI: 10.3345/cep.2026.01473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pediatrics, erschienen am 15.08.2026. Verfasst von Bashair Alabbasi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Nephrology Department; Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apparent mineralocorticoid excess (AME) is a rare autosomal recessive form of hypertension caused by dysfunction of the 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) enzyme.Mutation in the 11β-hydroxysteroid dehydrogenase type 2 HSD11B2 gene located on chromosome 16q22.1,2) 11HSD-2 is expressed in principal cells of the collecting ducts.Activity loss of 11β-HSD2 leads to continuous cortisol accumulation, overstimulation of the mineralocorticoid receptor, increased sodium reabsorption, and potassium loss.Clinical characterization includes early-onset hypertension, hypokalemia, metabolic alkalosis, suppressed plasma renin activity, and absence of circulating aldosterone.3,4) AME is classified into types I and II. 1) A 2-year-old girl was referred for evaluation of hypokalemia identified during admission for acute tonsillitis.The patient had a 3-day history of fever, upper respiratory symptoms, poor oral intake, and reduced activity.Her fever reached 38°C at home and was accompanied by cough and decreased feeding.Initially diagnosed with A rare genetically confirmed case of apparent mineralocorticoid excess syndrome due to a homozygous HSD11B2 variant in a 2-year-old child with severe hypertension: response to targeted therapy

Autor:innen und Institutionen

  • Pediatric Nephrology Department; Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Pediatric Nephrology Department; Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Mugahid1111@hotmail.com.

Zitieren

APA

Alabbasi, B., Elamin, M., Alsallum, G., & Alzahrany, G. (2026). A rare genetically confirmed case of apparent mineralocorticoid excess syndrome due to a homozygous HSD11B2 variant in a 2-year-old child with severe hypertension: response to targeted therapy. Clinical and Experimental Pediatrics, 69(8), 676-679. https://doi.org/10.3345/cep.2026.01473

Vancouver

Alabbasi B, Elamin M, Alsallum G, Alzahrany G. A rare genetically confirmed case of apparent mineralocorticoid excess syndrome due to a homozygous HSD11B2 variant in a 2-year-old child with severe hypertension: response to targeted therapy. Clinical and Experimental Pediatrics. 2026;69(8):676-679. doi:10.3345/cep.2026.01473

BibTeX
@article{Alabbasi2026,
  author = {Alabbasi, Bashair and Elamin, Mugahid and Alsallum, Ghadah and Alzahrany, Ghada},
  title = {A rare genetically confirmed case of apparent mineralocorticoid excess syndrome due to a homozygous HSD11B2 variant in a 2-year-old child with severe hypertension: response to targeted therapy},
  journal = {Clinical and Experimental Pediatrics},
  year = {2026},
  volume = {69},
  number = {8},
  pages = {676--679},
  doi = {10.3345/cep.2026.01473}
}
Kostenlos starten →